GATA2 exosomal mRNA: A novel urine biomarker for the diagnosis of clinically significant prostate cancer.

Authors

• William Kelly

Publication/Presentation Date

2-2019

Volume

37

Issue

7

Published In/Presented At

DOI: 10.1200/JCO.2019.37.7_suppl.18

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article